Home
AI
World
Politics
Health
Crime & justice
Science & technology
Social issues
Sports
Money
Entertainment
Environment/energy
Military
Culture
Weather
Media






Home
Bias Split
Public FiguresControversies

Sign Up for Our Free Newsletters
Sign Up for Our Free Newsletters

Sign Up!
Sign Up Now!

How our sliders workAboutContact UsNewsletter Archive
MediaFAQGlossaryPrivacy Policy
  1. Home

Mounjaro Outperforms Wegovy in Weight Loss Drug Trial

  • #Obesity
  • #Health
  • #Medicine & healthcare
  • #Research
  • #Australia
Mounjaro Outperforms Wegovy in Weight Loss Drug Trial
story
MAY 14
Above: Slimming syringes of the brands "Wegovy", "Ozempic," and "Mounjaro" are sold in the Achat pharmacy in Mitte, Berlin, Germany, on July 11, 2024. Image copyright: Jens Kalaene/Contributor/picture alliance via Getty Images
story last updated MAY 15

The Spin

Pro-establishment narrative

Weight loss drugs have made historic leaps and bounds in the fight to end obesity, now rivaling surgery's impact. While Mounjaro leads with 25% weight loss, Wegovy's 14% reduction is no small feat either. That said, side effects like nausea and muscle loss highlight risks. Ongoing research is vital to ensure these miracle drugs are as safe as possible, cementing their revolutionary role in tackling the global obesity crisis.

The IndependentThe i Paper

Establishment-critical narrative

Mounjaro and Wegovy are certainly groundbreaking for obesity, but will never be cures. Not only do they contain side effects like nausea and muscle loss, but they dodge the real issue: a food system pushing processed junk. Natural, whole foods can keep everyone in better shape, especially those genetically prone to obesity. Of course, research must continue to refine drug safety, but diet reform will always trump pharmaceutical fixes.

GuardianAmerican Conservative

Metaculus Prediction


Articles on this story

The toxic debate about obesity rages on. But at least we know if Mounjaro or Wegovy is better for weight loss | Zoe Williams
GuardianMAY 2